Company Description
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source.
The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.
Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox.
CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting.
It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings.
The company is headquartered in Petach Tikva, Israel.
| Country | Israel |
| IPO Date | Aug 21, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 164 |
| CEO | Erez I. Meltzer |
Contact Details
Address: Ofer Tech Park, 94 Shlomo Shmeltzer Road Petach Tikva, L3 4970602 Israel | |
| Phone | 972-37359202 |
| Website | nanox.vision |
Stock Details
| Ticker Symbol | NNOX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 0001795251 |
| CUSIP Number | M70700105 |
| ISIN Number | IL0011681371 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Erez I. Meltzer | Chief Executive Officer and Director |
| James M. Dara | GM of Source and Services Division and Head of Nanox USA |
| Ofir Koren | General Manager of Nanox.ARC Division |
| Ran Daniel | Chief Financial Officer |
| Marina Gofman Feler | Chief Legal Officer |
| Tamar Aharon Cohen | Executive Vice President and Chief Marketing Officer |
| Dr. Orit Wimpfheimer | Chief Medical Officer and Vice President of Product Nanox AI |
| Gali Yahav Attias | Vice President of Corporate Resources and Chief of Staff |
| Dr. Guy Yoskovitz Ph.D. | Chief Clinical Officer |
| Michael Attias | Vice President and Head of Robodiology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 8, 2024 | EFFECT | Notice of Effectiveness |
| May 8, 2024 | 6-K | Report of foreign issuer |
| Apr 22, 2024 | 6-K | Report of foreign issuer |
| Apr 22, 2024 | POS AM | Post-Effective amendments for registration statement |
| Apr 22, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Apr 22, 2024 | POSASR | Filing |
| Apr 1, 2024 | 6-K | Report of foreign issuer |
| Mar 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | 6-K | Report of foreign issuer |
| Feb 6, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |